Beranda › Kolitis Ulseratif › Texas › San Antonio
Uji klinis Kolitis Ulseratif di San Antonio, TX
16 studi untuk Kolitis Ulseratif mencari peserta di lokasi sekitar San Antonio (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Menerima pesertaFase 3
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Menerima pesertaFase 2
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
Menerima pesertaFase 2
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 2
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Menerima pesertaFase 1/2Sukarelawan sehat diterima
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Menerima pesertaFase 2
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Menerima pesertaFase 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Menerima pesertaFase 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Menerima pesertaFase 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Menerima pesertaFase 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 3
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Menerima pesertaFase 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Menerima pesertaStudi observasional
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
Uji klinis Kolitis Ulseratif di kota lain
- New York City, NY23 studi
- Orlando, FL22 studi
- Miami, FL21 studi
- Houston, TX17 studi
- Tacoma, WA15 studi
- Chicago, IL15 studi
- San Diego, CA15 studi
- Tyler, TX14 studi
- Colorado Springs, CO14 studi
- Los Angeles, CA13 studi
- St. Louis, MO13 studi
- Washington, DC12 studi
Studi lain di San Antonio
- Kanker Paru Non-Sel Kecil59 studi
- Kanker Kolorektal46 studi
- Kanker Payudara46 studi
- Kanker Metastatik44 studi
- Kanker (semua jenis)41 studi
- Obesitas40 studi
- Diabetes Tipe 237 studi
- Kelebihan Berat Badan34 studi
- Kanker Ovarium31 studi
- Kanker Pankreas31 studi
- Kanker Prostat28 studi
- Kanker Endometrium27 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.